cevimeline (Evoxac, Saligren)
Jump to navigation
Jump to search
Introduction
Tradename: Evoxac.
Indications
dry mouth due to Sjogren's syndrome
Dosage
Tabs: 30 mg.
Adverse effects
- cholinergic effects
Mechanism of action
stimulates salivary secretion
More general terms
Additional terms
References
- ↑ Prescriber's Letter 7(5):29, May 2000
Database
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=83927
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5284532
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=83898
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=123603
- PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2684